alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<page>								       EXHIBIT 32.01



CERTIFICATION OF PRESIDENT PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Morgan Stanley Principal
Plus Fund L.P. (the ?Partnership?) on Form 10-K for the period
ended December 31, 2007, as filed with the Securities and Exchange
Commission on the date hereof (the ?Report?), I, Walter Davis,
President of Demeter Management Corporation, the general partner
of the Partnership, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:

(1)		The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.







By:	/s/Walter Davis

Name:	   Walter Davis
Title:	   President

Date:	   March 28, 2008
Commodity 

2005 

Pounds 

Applied

2006 

Pounds 

Applied

2007 

Pounds 

Applied

Vertebrate Control 172.48 1406.12 1184.95

Chemical Total 172.48 1406.12 1184.95

Prepared: June 30, 2009

Cal DPR Data: http://www.cdpr.ca.gov/docs/pur/purmain.htm

Publicly available data from the California Department of Pesticide 

Regulation (CADPR) was used to produce the following table outlining 

the pounds of Polybutene used in California over the three most recent 

years available (2005-2007). 

Polybutene (011402) Cal DPR Usage Data
<page>				       EXHIBIT 32.01



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Dean Witter Principal Plus
Fund L.P. (the ?Partnership?) on Form 10-K for the period ended
December 31, 2004 as filed with the Securities and Exchange
Commission on the date hereof (the ?Report?), I, Jeffrey A.
Rothman, President, Demeter Management Corporation, the general
partner of the Partnership, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to the best of my knowledge:

(1)		The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.







By:	/s/Jeffrey A. Rothman

Name:	   Jeffrey A. Rothman
Title:	   President

Date:	   March 31, 2005
February 2022

There were 9 surveillance inspections conducted at 8 different sites for a total of 90

fish sampled this month. Samples are targeted to moribund and fresh mortalities 

when possible. The water temperatures remained steady in response to the cold air 

temperatures. All sites with fish in the water remained Category 1 and were 

scheduled for monthly sampling. Routine harvest continued. No cages were 

confirmed positive this month.

Date Number of 

Samples

Confirmed Positive Cages Cumulative 

Program Samples

March 2021 46 0 23597

April 2021 50 0 23647

May 2021 90 0 23737

June 2021 120 0 23857

July 2021 110 0 23967

August 2021 122 0 24089

September 2021 99 0 24188

October 2021 84 0 24272

November 2021 89 0 24361

December 2021 80 0 24441

January 2022 80 0 24521

February 2022 90 0 24611
Fourth Court of Appeals

San Antonio, Texas

July 29, 2019

No. 04-19-00318-CV

Leticia R. BENAVIDES,

Appellants

v.

Cristina B. ALEXANDER as permanent guardian of the person of Carlos Y. Benavides, Jr., et 

al.,

Appellees

From the 49th Judicial District Court, Webb County, Texas

Trial Court No. 2012CVQ-000161-D1

Honorable Jose A. Lopez, Judge Presiding

O R D E R

The reporter’s record in this case was originally due on June 13, 2019. On June 14, 2019, 

this court notified the court reporter by letter that the reporter’s record was late and must be filed 

by no later than July 15, 2019. On July 17, 2019, the court reporter filed a notification of late 

record requesting an additional sixty (60) days to file the reporter’s record. The request is 

GRANTED. It is therefore ORDERED that the court reporter file the reporter’s record by no 

later than September 16, 2019. 

Given that the court reporter has been given extensions of time to file the reporter’s 

record in this case totaling ninety (90) days, the court reporter is advised that no further 

requests for extension of time to file the reporter’s record will be granted. If the reporter’s 

record is not filed by September 16, 2019, the court reporter is further advised that an 

order may issue directing her to appear before this court in person and show cause why she 

should not be held in contempt for failing to file the record.

The clerk of this court shall cause a copy of this order to be served on the court reporter

by certified mail, return receipt requested, or give other personal notice of this order with proof 

of delivery. Because “[t]he trial and appellate courts are jointly responsible for ensuring that the 

appellate record is timely filed,” TEX. R. APP. P. 35.3(c), the clerk of the court is directed to serve 

a copy of this order on the Honorable Jose A. Lopez, Judge of the 49th Judicial District Court.
_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 29th day of July, 2019.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
# C_2020230EN.01002401.xml

| 13.7.2020 | EN | Official Journal of the European Union | C 230/24 |
| --- | --- | --- | --- |

13.7.2020

EN

Official Journal of the European Union

C 230/24

---

Judgment of the General Court of 28 May 2020 — YG v Commission

(Case T-518/18) (1)

(Civil service - Officials - Promotion - 2017 promotion procedure - Decision not to promote the applicant to grade AST 9 - Comparison of the merits - Equal treatment - Manifest error of assessment - Duty to state reasons)

(2020/C 230/29)

Language of the case: English

Parties

Applicant: YG (represented by: S. Rodrigues and A. Champetier, lawyers)

Defendant: European Commission (represented by: G. Berscheid, B. Eggers and L. Radu Bouyon, acting as Agents)

Re:

Application under Article 270 TFEU for annulment of the Commission’s decision of 13 November 2017 not to promote the applicant in the 2017 promotion procedure.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders the European Commission to pay the costs. |
| --- | --- |

2.

Orders the European Commission to pay the costs.

---

(1)  OJ C 399, 5.11.2018.

---
May 2019

There were 8 surveillance inspections conducted at 8 different sites for a total of 92

fish sampled this month. Samples are targeted to moribund and fresh mortalities 

when possible. The water temperatures continued to increase in response to warmer 

air temperatures. There were no cages confirmed this month. All of the sites with fish 

in the water remained Category 1 and were scheduled for monthly sampling.

Date Number of 

Samples

Confirmed Positive Cages Cumulative 

Program Samples

June 2018 50 0 20499

July 2018 50 0 20549

August 2018 50 0 20599

September 2018 40 0 20639

October 2018 40 0 20679

November 2018 40 0 20719

December 2018 45 0 20764

January 2019 40 0 20804

February 2019 50 0 20854

March 2019 115 0 20969

April 2019 108 0 21077

May 92 0 21169
#### Will v. Sutherland

21063

9/18/98

Affirmed
Order entered Decem ber 9 , 2014

In The 

## Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 14 - 00770 - CR No. 05 - 14 - 00771 - CR STEVEN DWAYNE FERREL L, Appellant V. THE STATE OF TEXAS, Appellee On Appeal from the Criminal District Court No. 5 Dallas County, Texas Trial Court Cause No s . F12 - 72590 - L , F14 - 54495 - L 

### O RDER Before Justices Bridges, Lang

- Miers, and Myers Based on the Court’s opinion of this date, we DIRECT the Clerk of the Court to issue the mandate s in these appeals INSTANTER

. /s/ ELIZABE TH LANG

- MIERS JUSTICE
# C_2019399EN.01005001.xml

| 25.11.2019 | EN | Official Journal of the European Union | C 399/50 |
| --- | --- | --- | --- |

25.11.2019

EN

Official Journal of the European Union

C 399/50

---

Judgment of the General Court of 17 September 2019 — TrekStor v EUIPO (Theatre)

(Case T-399/18) (1)

(EU trade mark - Application for EU word mark Theatre - Absolute ground for refusal - Descriptive character - No distinctive character - Article 7(1)(b) and (c) of Regulation (EU) 2017/1001)

(2019/C 399/60)

Language of the case: German

Parties

Applicant: TrekStor Ltd (Hong-Kong, China) (represented by: O. Spieker, A. Schönfleisch, M. Alber and N. Willich, lawyers)

Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 26 April 2018 (Case R 2238/2017-2) relating to an application for registration of the word sign Theatre as an EU trade mark.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders TrekStor Ltd to pay the costs. |
| --- | --- |

2.

Orders TrekStor Ltd to pay the costs.

---

(1)  OJ C 294, 20.8.2018.

---
March 10, 2015 

Mr. Ronald J. Strah 

Digital Wave Videos, LLC 

7403 Father Frascati Drive 

Cleveland, OH 44102 

Dear Mr. Strah: 

This letter is to inform you that we are unable to process your request for an exemption. It 

explains why we cannot process your request and what you should do in the next 30 days. 

Why We Cannot Process Your Request 

We entered your February 17, 2015, exemption request on behalf of Digital Wave Videos 

LLC into the public docket (No. FAA-2015-0375), but we are unable to process your request 

any further. The information you sent does not comply with the requirements of § 11.81 

(copy enclosed). For us to consider the request any further, you must send us all of the 

following: 

 The specific section or sections of 14 CFR from which you seek relief and the extent of 

the relief you seek. 

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole. 

 The reasons why the exemption would not adversely affect safety or how the exemption 

would provide a level of safety at least equal to that provided by the rule from which you 

seek an exemption. 

 Any additional information, views, or arguments available to support your request. 

What You Should Do 

If you want us to process your request any further, you must send the information described 

earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your 

petition for exemption at least 120 days before the proposed effective date of the exemption. 
2 

If We Do Not Hear From You 

If we do not hear from you within 30 days, we will close the docket without notifying you 

further. If you have any questions or require additional time, you may call (202) 267-9677. 

Sincerely, 

/s/ 

Nia Daniels 

Program Analyst, Airmen and 

 Airspace Rules Division 

Enclosure
OFFICE, OF THE ATTORNEY GENERAL OF TEXAS AUSTIN M..~,

Gal.0 c. MANN Juno 1, 1939
,- .**nAs /

### RoweYer, ywr Quomtial

Qellnot relateto 

## ths 8qqart or paupana

Tbeputlosmffer~thetmltems OS Jmmpital

trfld~ ran lbtdl#aat 6iak mad there l8 PO QUeb?iial

am to dwther or a& tiledpeopfe%r8 pauper8 end ead.ngwlthln~th8 

### ~ovlelan,ofart1010ES5Idowa set out. Artia1e 4ks3, RarisaedClvil 

### stetuteu 0s Terau, prmidem aa fallowa

***Xf** 

### there **im a**  **remalar a8tia~**  **publle. hollpLt8l**  **ia** the **eowty,** th! **clx&r&mlaler8 ’**  **mart ehll**  **provl4s tar**  **8eridlssg the**  **ilageat oldc**  **of** 

### the **oouaty fo**  **maeh hasplh,l~**  **lf mare**  

### thmone mtohrswpltaZQd8tsln theoocmtt, the l..uw pat1fmt 

### shallhave the rl&t.ttJ meleot nhleh oae of themha shag be sent tar. The l lthmlty or the Oaaeisslaieti' Gorat ti llaltmd ln proridfngfar treotrPent of the tnaie*ot;

doL to 

### publia

hompltala

wlthln the oouuty, end the authority %a exoluded to aaadauoh Indigent sic& to private ho+ pitalmwitbin 0ru1thout the aounty, or 

### to publiohoi@- tals ritbo!xt

the Qouut~~ EiU.aap Gowty Y. Va1ley,?aptifat &sp%t8l, ZQ 3% (2d) 456. ..: '.-' 3

. Therefore, it is our'optnion and you **are** ao **ad vised**  that the Hall~ounty Gomaistianers' Gourt hs xm

### no::. car1 E~;rian,

Juac 1, 1999,Mge 9
Veterinary Services – Safeguarding Animal Health Federal Relay Service

 An Equal Opportunity Employer (Voice/TTY/ASCII/Spanish)

 1-800-877-8339

May 23, 2003

CENTER FOR VETERINARY BIOLOGICS NOTICE NO. 03-08

Subject: Purpose of the Equine Infectious Anemia Weak Positive Serum Sample

as Outlined in Veterinary Services Memorandum No. 555.16

To: Biologics Licensees, Permittees, and Applicants

Veterinary Services Management Team

Directors, Center for Veterinary Biologics

The purpose of this notice is to inform interested parties of the intended function of the 

Equine Infectious Anemia (EIA) weak positive serum sample required in the testing 

procedures to be followed by approved EIA laboratories as outlined in Veterinary 

Services (VS) Memorandum No. 555.16.

According to VS Memorandum No. 555.16, a weak positive EIA serum sample is 

available from the National Veterinary Services Laboratories (NVSL). The NVSL EIA 

serum sample is intended to remind approved personnel of the expected weak positive 

precipitation lines obtained in an agar gel immunodiffusion (AGID) test. This serum 

sample does not represent a weak positive threshold sample as the sample has a higher 

antibody concentration. If manufacturers wish to evaluate the NVSL EIA serum, they 

may purchase the sample from the NVSL.

The NVSL EIA serum sample is not intended to be used by manufacturers of AGID 

Equine Infectious Anemia Virus Antibody Test Kits during the standardization of the 

antigen in individual serials. The Center for Veterinary Biologics-Policy, Evaluation, 

and Licensing (CVB-PEL) has available the current EIA weak positive threshold serum 

that manufacturers should use for antigen standardization of each AGID serial. The EIA 

threshold serum is available to manufacturers upon request to the CVB-PEL.

/s/ Richard E. Hill, Jr.

Richard E. Hill, Jr.

Director

Center for Veterinary Biologics

United States

Department of

Agriculture

Marketing and

Regulatory 

Programs

Animal and Plant

Health Inspection

Service

Veterinary Services

Center for Veterinary 

Biologics

Suite 104

510 South 17th Street

Ames, IA 50010

(515) 232-5785

FAX (515) 232-7120
<PAGE>   1
                                                                    EXHIBIT 11.1



                               CAERE CORPORATION





                        STATEMENT REGARDING COMPUTATION

                           OF NET EARNINGS PER SHARE

                     (IN THOUSANDS, EXCEPT PER SHARE DATA)





<TABLE>
<CAPTION>
                                                                 YEARS ENDED DECEMBER 31
                                                                 -----------------------
                                                        1996                1995               1994
                                                        ----                ----               ----
<S>                                               <C>                <C>                <C>
Net earnings                                      $          396     $         2,397    $         2,384
                                                  ==============     ===============    ===============

Shares used in per share computation:

  Weighted average common shares outstanding              13,120              13,172             12,649

  Common stock equivalents                                   199                 366                487
                                                  --------------     ---------------    ---------------

                                                          13,319              13,538             13,136
                                                  ==============     ===============    ===============



Primary earnings per share                        $         0.03     $          0.18    $          0.18
                                                  ==============     ===============    ===============
</TABLE>
#### Ream v. Glass

16435

11/01/94

Affirmed
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          57,900
<SECURITIES>                                         0
<RECEIVABLES>                                   33,300
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               105,100
<PP&E>                                       1,577,700
<DEPRECIATION>                                 291,600
<TOTAL-ASSETS>                               1,400,300
<CURRENT-LIABILITIES>                           43,400
<BONDS>                                        799,500
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     554,100
<TOTAL-LIABILITY-AND-EQUITY>                 1,400,300
<SALES>                                              0
<TOTAL-REVENUES>                               232,000
<CGS>                                                0
<TOTAL-COSTS>                                  138,500
<OTHER-EXPENSES>                                   600
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              44,900
<INCOME-PRETAX>                                 50,800
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             50,800
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    50,800
<EPS-BASIC>                                       1.53
<EPS-DILUTED>                                     1.53


</TABLE>
[Federal Register Volume 88, Number 238 (Wednesday, December 13, 2023)]
[Notices]
[Page 86349]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27296]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Glioma, Multiple Sclerosis, and Neuroinflammation.
    Date: December 22, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Salma Asmat Quraishi, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0592, 
<a href="/cdn-cgi/l/email-protection#ec9f8d80818dc29d999e8d859f8485ac828584c28b839a"><span class="__cf_email__" data-cfemail="81f2e0edece0aff0f4f3e0e8f2e9e8c1efe8e9afe6eef7">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: December 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-27296 Filed 12-12-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2018142EN.01006701.xml

| 23.4.2018 | EN | Official Journal of the European Union | C 142/67 |
| --- | --- | --- | --- |

23.4.2018

EN

Official Journal of the European Union

C 142/67

---

Action brought on 1 March 2018 — Monster Energy v EUIPO — Nordbrand Nordhausen (BALLER’S PUNCH)

(Case T-134/18)

(2018/C 142/86)

Language in which the application was lodged: English

Parties

Parties

Applicant: Monster Energy Company (Corona, California, United States) (represented by: P. Brownlow, Solicitor)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Other party to the proceedings before the Board of Appeal: Nordbrand Nordhausen GmbH (Nordhausen, Germany)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Applicant of the trade mark at issue:

Trade mark at issue: EU word mark BALLER’S PUNCH — Application for registration No 14 823 306

Trade mark at issue:

Procedure before EUIPO: Opposition proceedings

Procedure before EUIPO

Contested decision: Decision of the First Board of Appeal of EUIPO of 12 December 2017 in Case R 998/2017-1

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | annul the decision of the Opposition Division of 13 March 2017 in Opposition B002643172; |
| --- | --- |

—

annul the decision of the Opposition Division of 13 March 2017 in Opposition B002643172;

| — | register the opposed mark for all goods covered by the application; |
| --- | --- |

—

register the opposed mark for all goods covered by the application;

| — | order EUIPO to bear its own costs and pay those of the Applicant. |
| --- | --- |

—

order EUIPO to bear its own costs and pay those of the Applicant.

Plea in law

Plea in law

| — | Infringement of Article 8(1)(b) of Regulation No. 2017/1001. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation No. 2017/1001.

---
889 P.2d 65

SUPREME COURT OF HAWAII

#### Doty v. Tanaka

16614

11/01/94

Affirmed